CEA Valduc

Recent papers from CEA Valduc

1. Insights into rhabdomyosarcoma in the adolescent and young adult population: a comprehensive clinical study from the French Society of Pediatric Oncology (SFCE) Malignant Mesenchymal Tumor (MMT) Committee and the French Sarcoma Group (GSF-GETO)ESMO Open · 2026
2. Structural and mechanical characterization of ultra-low-density aerogelsJournal of Non-Crystalline Solids · 2026
3. Using carbonate ions to investigate Ce(III) ions precipitation in molten chlorides (NaCl-KCl)Journal of Nuclear Materials · 2026
4. The CO.33/BATTMAN trial: A phase 3 randomized study of botensilimab + balstilimab versus best supportive care in chemorefractory unresectable colorectal adenocarcinoma that is not dMMR/MSI-H.Journal of Clinical Oncology · 2026
5. Evaluation of the combination of regorafenib + avelumab in patients with HPV-associated cancer: The phase II REGOMUNE study.Journal of Clinical Oncology · 2026
6. A62-08 Diagnostic Accuracy and Clinical Agreement Between the Global Lung Function Initiative 2012 (GLI-2012) and 2022 (GLI-2022) Reference Equations in Pediatric Spirometry at High Altitude in Bogotá, ColombiaAmerican Journal of Respiratory and Critical Care Medicine · 2026
7. A calibrated experimental platform at the LMJ facility to produce and characterize high radiant energy xenon and krypton x-ray sourcesPhysics of Plasmas · 2026
8. Tem or Esd in Early Rectal Tumors: A Clinical & Cost-Effectiveness AnalysisGastroenterology · 2026
9. ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO TrialClinical Cancer Research · 2026
10. Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trialThe Lancet Healthy Longevity · 2026
11. Contemporary neoadjuvant strategies for rectal cancer: The GRECCAR snapshot studyColorectal Disease · 2026
12. Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III TrialJournal of Clinical Oncology · 2025
13. First direct-drive implosions and produced neutrons for development of a particle source platform on the laser megajoulePhysics of Plasmas · 2025
14. Viscoplasticity and phase field modelling of the delayed cracking of oxide intrusions at grain boundariesJournal of the Mechanics and Physics of Solids · 2025
15. High temperature EBSD experiment versus crystallographic reconstruction to study phase transformation induced microstructures - Application examples for steelsMaterials Characterization · 2025
16. Recent Progress in the Characterization of EOS Targets for LMJ ExperimentsFusion Science & Technology · 2025
17. Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma‐based collection of 77 patients with locally advanced unresectable esophageal cancerInternational Journal of Cancer · 2025
18. Effect of laser produced plasma bubbles and wall expansion on laser beams propagation inside gas filled halfraum cavityPhysics of Plasmas · 2025
19. Experimental and numerical characterization of high-energy point-like x-ray sources for radiography applications at the LMJ-PETAL laser facilityPhysics of Plasmas · 2025
20. Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair GenesCancers · 2025